Dual-layer detector spectral CT for predicting p16 status in head and neck squamous cell carcinoma

被引:1
|
作者
Li, Zhijun [1 ,2 ,3 ,4 ]
Ye, Lu [1 ,2 ,3 ,4 ]
Xiao, Jianyu [1 ,2 ,3 ,4 ]
Lu, Xiaomei [5 ]
Ye, Zhaoxiang [1 ,2 ,3 ,4 ]
机构
[1] Tianjin Med Univ, Dept Radiol, Canc Inst & Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ Canc, Natl Clin Res Ctr Canc, Inst & Hosp, Tianjin, Peoples R China
[3] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
[4] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[5] Philips Healthcare, CT Clin Sci CT, Shenyang, Peoples R China
关键词
Head and neck squamous cell carcinoma; Spectral CT; HPV; p16; Quantitative analysis; HUMAN-PAPILLOMAVIRUS; SURVIVAL;
D O I
10.1007/s42058-023-00123-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundHPV-positive head and neck squamous cell carcinoma (HNSCC) differs from HPV-negative HNSCC in clinical features, biological behavior, pathological manifestations, cytogenetics and tend to have better outcome. Immunohistochemical (IHC) p16 staining is highly sensitive for HPV status exam, but has a certain probability of false positives, and the accurate result of p16 expression could be challenging due to the limitation of the biopsy location and quantity. As a non-invasive approach, dual-layer detector spectral CT (DLSCT) provides multi-parameter quantitative analysis, which could help better reflect the changes of tumor characteristics. Hence, this study aimed to evaluate the spectral-derived differences between the p16( +) and p16(-) group of HNSCC so as to explore the application in preoperative diagnosis in differentiating the p16 expression status of HNSCC.Materials and methodsThe spectral data of 35 patients with biopsy confirmed HNSCC were retrospectively analyzed and compared between p16( +) (n = 11) and p16(-) (n = 25) group. All statistical analyses were performed on SPSS v26.0.ResultsEffective atomic number (Zeff), slope value of virtual monoenergetic image (VMI), and normalized iodine density (NID) of p16( +) group were all significantly lower than p16(-) group (8.36 (8.24, 8.42) vs. 8.57 (8.38, 8.85), 2.45 (2.22, 2.64) vs. 3.06 (2.50, 3.82), 0.43 & PLUSMN; 0.09 vs. 0.55 & PLUSMN; 0.14, respectively) (p < 0.05). Besides, NID showed a good ability to discriminate p16(-) HNSCC from p16( +) HNSCC (AUC = 0.788) with a threshold value of 0.495.ConclusionDLSCT could be helpful for the differentiation of p16 expression in HNSCC.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 50 条
  • [31] The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma
    da Costa, Alexandre A. B. A.
    Costa, Felipe D'Almeida
    Araujo, Daniel Vilarim
    Guedes Camandaroba, Marcos Pedro
    Fonseca de Jesus, Victor Hugo
    Oliveira, Audrey
    Fonseca Alves, Ana Caroline
    Stecca, Carlos
    Machado, Larissa
    Feraz de Oliveira, Andrea Cruz
    de Oliveira, Thiago Bueno
    Nicolau, Ulisses Ribaldo
    Cordeiro de Lima, Vladmir Claudio
    MEDICAL ONCOLOGY, 2019, 36 (01)
  • [32] p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro
    Liggett, WH
    Sewell, DA
    Rocco, J
    Ahrendt, SA
    Koch, W
    Sidransky, D
    CANCER RESEARCH, 1996, 56 (18) : 4119 - 4123
  • [33] Radiomics based on dual-layer spectral detector CT for predicting EGFR mutation status in non-small cell lung cancer
    Jin, Dan
    Ni, Xiaoqiong
    Tan, Yanhuan
    Yin, Hongkun
    Fan, Guohua
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2025, 26 (02):
  • [34] p16 and p53 expression status in head and neck squamous cell carcinoma: a correlation with histological, histoprognostic and clinical parameters
    Karpathiou, Georgia
    Monaya, Alessandra
    Forest, Fabien
    Froudarakis, Marios
    Casteillo, Francois
    Dumollard, Jean Marc
    Prades, Jean Michel
    Peoc'h, Michel
    PATHOLOGY, 2016, 48 (04) : 341 - 348
  • [35] CT-based Radiomics Predicting HPV Status in Head and Neck Squamous Cell Carcinoma
    Shi, Z.
    Zhang, C.
    Welch, M.
    Kalendralis, P.
    Leonard, W.
    Dekker, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S515 - S515
  • [36] CT-based Radiomics Predicting HPV Status in Head and Neck Squamous Cell Carcinoma
    Shi, Z.
    Zhang, C.
    Welch, M.
    Petros, P.
    Wee, L.
    Dekker, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 18 - 19
  • [37] Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status
    Abi-Raad, Rita
    Prasad, Manju L.
    Gilani, Syed
    Garritano, James
    Barlow, Deborah
    Cai, Guoping
    Adeniran, Adebowale J.
    CANCER CYTOPATHOLOGY, 2021, 129 (05) : 394 - 404
  • [38] Predicting Residual Neck Disease in Patients With Oropharyngeal Squamous Cell Carcinoma Treated With Radiation Therapy Utility of p16 Status
    Shonka, David C., Jr.
    Shoushtari, Asal N.
    Thomas, Christopher Y.
    Moskaluk, Christopher
    Read, Paul W.
    Reibel, James F.
    Levine, Paul A.
    Jameson, Mark J.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (11) : 1126 - 1132
  • [39] Dual-layer spectral-detector CT for predicting microsatellite instability status and prognosis in locally advanced gastric cancer
    Zhu, Yongjian
    Wang, Peng
    Wang, Bingzhi
    Jiang, Zhichao
    Li, Ying
    Jiang, Jun
    Zhong, Yuxin
    Xue, Liyan
    Jiang, Liming
    INSIGHTS INTO IMAGING, 2023, 14 (01)
  • [40] p16 immunocytochemistry on aspirate smears of neck masses: Another option for determining the HPV status in metastatic head and neck squamous cell carcinoma
    Griffith, Christopher C.
    CANCER CYTOPATHOLOGY, 2019, 127 (07) : 423 - 425